Type 2 diabetes and the risk of colorectal adenomas: Black women's health study

American Journal of Epidemiology

Volumn 179, Issue 1, 2014, Pages 112-119

  Dash, Chiranjeev ^a   Palmer, Julie R ^b   Boggs, Deborah A ^b   Rosenberg, Lynn ^b   Adams Campbell, Lucile L ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

African American women; colorectal adenoma; colorectal cancer; diabetes; insulin

Indexed keywords

INSULIN;

DIABETES; DISEASE CONTROL; LITERATURE REVIEW; RISK FACTOR; WOMENS HEALTH;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL POLYP; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; SIGMOIDOSCOPY; WOMEN'S HEALTH; YOUNG ADULT;

AFRICAN AMERICAN WOMEN; COLORECTAL ADENOMA; COLORECTAL CANCER; DIABETES; INSULIN;

ADENOMA; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; DIET; EDUCATIONAL STATUS; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINAL POLYPS; MIDDLE AGED; RISK FACTORS; WOMEN'S HEALTH;

UNITED STATES;

EID: 84891367955     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt227     Document Type: Article

References (45)

1. Howlader N, Noone A, Krapcho M, et al. SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda, MD: National Cancer Institute; 2012. (http://Seer. cancer.gov/csr/1975-2009-pops09/). (Accessed March 25, 2013).
2. Rex DK, Khan AM, Shah P, et al. Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc. 2000;51(5):524-527. (Pubitemid 30322333)
3. Lieberman DA, Holub JL, Moravec MD, et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300(12): 1417-1422.
4. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6(2):164-179.
5. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3(8):687-695. (Pubitemid 24377963)
6. Larsson SC, Orsini N,Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005; 97(22):1679-1687. (Pubitemid 41672234)
7. Campbell PT, Deka A, Jacobs EJ, et al. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology. 2010;139(4):1138-1146.
8. Limburg PJ, Vierkant RA, Fredericksen ZS, et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study. Am J Gastroenterol. 2006;101(8):1872-1879. (Pubitemid 44166600)
9. Luo J, Chlebowski R, Liu S, et al. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control. 2013;24(3):577-585.
10. He J, Stram DO, Kolonel LN, et al. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer. 2010;103(1):120-126.
11. Flood A, Strayer L, Schairer C, et al. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control. 2010;21(8):1277-1284.
12. Elwing JE, Gao F, Davidson NO, et al. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women. Am J Gastroenterol. 2006;101(8):1866-1871. (Pubitemid 44166599)
13. Marugame T, Lee K, Eguchi H, et al. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control. 2002;13(10):917-921. (Pubitemid 36169474)
14. Eddi R, Karki A, Shah A, et al. Association of type 2 diabetes and colon adenomas. J Gastrointest Cancer. 2012;43(1):87-92.
15. Suh S, Kang M, Kim MY, et al. Korean type 2 diabetes patients have multiple adenomatous polyps compared to nondiabetic controls. J Korean Med Sci. 2011;26(9):1196-1200.
16. Kim BC, Shin A, Hong CW, et al. Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control. 2012;23(5):727-735.
17. Tsilidis KK, Brancati FL, Pollak MN, et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control. 2010;21(1):1-10.
18. Corpet DE, Jacquinet C, Peiffer G, et al. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer. 1997;27(3):316-320. (Pubitemid 27161531)
19. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev. 1996; 5(12):1013-1015. (Pubitemid 26415875)
20. Tran TT, Naigamwalla D, Oprescu AI, et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology. 2006;147(4):1830-1837.
21. Currie CJ, Poole CD, Gale EA. The influence of glucoselowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009;52(9):1766-1777.
22. Kabat GC, Kim MY, Strickler HD, et al. A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women. Br J Cancer. 2012;106(1):227-232.
23. Oliveria SA, Koro CE, Yood MU. The risk of cancer associated with antidiabetic therapy: a retrospective cohort study. Diabetes. 2006;55(suppl 1):A216.
24. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 2004;127(4):1044- 1050. (Pubitemid 39345873)
25. Wong P,Weiner MG, Hwang WT, et al. Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1833-1840.
26. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
27. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc. 1995;50(2): 56-58.
28. Russell C, Palmer JR, Adams-Campbell LL, et al. Follow-up of a large cohort of black women. Am J Epidemiol. 2001; 154(9):845-853. (Pubitemid 33000812)
29. Krishnan S, Rosenberg L, Djoussé L, et al. Overall and central obesity and risk of type 2 diabetes in U.S. black women. Obesity (Silver Spring). 2007;15(7):1860-1866. (Pubitemid 47264966)
30. Boggs DA, Rosenberg L, Ruiz-Narvaez EA, et al. Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr. 2010;92(4):960-966.
31. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology. 1990;1(1):58-64. (Pubitemid 20255624)
32. Laird N, Olivier D. Covariance analysis of censored survival data using log-linear analysis techniques. J Am Stat Assoc. 1981;76(374):231-240.
33. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst. 1999;91(6):542-547. (Pubitemid 29157063)
34. Ortiz AP, Thompson CL, Chak A, et al. Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer. 2012;118(7):1774-1781.
35. Sasaki Y, Takeda H, Sato T, et al. Serum interleukin-6, insulin, and HOMA-IR in male individuals with colorectal adenoma. Clin Cancer Res. 2012;18(2):392-399.
36. Ollberding NJ, Cheng I,Wilkens LR, et al. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2012;21(5):810-820.
37. Rinaldi S, Cleveland R, Norat T, et al. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer. 2010;126(7):1702-1715.
38. Joseph DA, King JB, Miller JW, et al. Prevalence of colorectal cancer screening among adults-behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(suppl):51-56.
39. Krishnan S, Rosenberg L, Singer M, et al. Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med. 2007;167(21): 2304-2309. (Pubitemid 350179524)
40. Margolis KL, Lihong Q, Brzyski R, et al. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008;5(3):240-247.
41. Schneider AL, Pankow JS, Heiss G, et al. Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012;176(8): 738-743.
42. Giovannucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121(4): 241-246.
43. Madlensky L, Daftary D, Burnett T, et al. Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiol Biomarkers Prev. 2007; 16(9):1898-1901. (Pubitemid 47450524)
44. US Census Bureau: Educational attainment in the US, March 1999.Washington, DC: US Department of Commerce; 2000. (http://www.census.gov/ population/socdemo/education/p20-528/tab01a.pdf). (Accessed July 25, 2013).
45. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion Division of Diabetes Translation. Atlanta, GA: National Diabetes Surveillance System; 2012. (http://www.cdc.gov/ diabetes/statistics/prev/national/menuage.htm). (Accessed July 25, 2013).